This is a demo store. No orders will be fulfilled.

OSU-T315 analog, 整合素连接激酶抑制剂

有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
O412290-1mg
1mg 现货 Stock Image
O412290-5mg
5mg 现货 Stock Image
O412290-10mg
10mg 现货 Stock Image
O412290-25mg
25mg 现货 Stock Image

基本描述

别名 OSU-T315 模拟
英文别名 ILK-IN-1
规格或纯度 Moligand™, ≥98%
英文名称 OSU-T315 analog
生化机理 OSU-T315 类似物(ILK-IN-1)是一种 Integrin 链接激酶(ILK)抑制剂,其 IC50 值为 0.6 μM,可通过使 AKT-Ser473 和其他 ILK 靶点(GSK-3β 和肌球蛋白轻链)去磷酸化来抑制 PI3K/AKT 信号传导。OSU-T315 可通过细胞凋亡和自噬导致细胞死亡。
储存温度 -20°C储存
运输条件 超低温冰袋运输
作用类型 抑制剂
作用机制 整合素连接激酶抑制剂
产品介绍


Information

OSU-T315 analog (ILK-IN-1) is an inhibitor of Integrin-linked kinase (ILK) with IC50 of 0.6 μM which inhibits PI3K/AKT signaling by dephosphorylation of AKT-Ser473 and other ILK targets (GSK-3β and myosin light chain). OSU-T315 causes cell death through apoptosis and autophagy.

纯度 ≥98%

关联靶点(人)

ILK Tchem 整合素连接蛋白激酶(Integrin-linked protein kinase) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
ABL1 Tclin Tyrosine-protein kinase ABL (18331 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
KIT Tclin Stem cell growth factor receptor (10667 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
GSK3B Tclin Glycogen synthase kinase-3 beta (11785 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
SRC Tclin Tyrosine-protein kinase SRC (10310 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
PDPK1 Tchem 3-phosphoinositide dependent protein kinase-1 (3758 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
IKBKB Tchem Inhibitor of nuclear factor kappa B kinase beta subunit (5554 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
JAK3 Tclin Tyrosine-protein kinase JAK3 (8349 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
RPS6KA1 Tchem Ribosomal protein S6 kinase alpha 1 (2796 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
JAK2 Tclin Tyrosine-protein kinase JAK2 (12915 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
PTK2 Tclin Focal adhesion kinase 1 (4730 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
MTOR Tclin Serine/threonine-protein kinase mTOR (13850 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
MET Tclin Hepatocyte growth factor receptor (10718 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
PRKCA Tchem Protein kinase C alpha (5923 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ZAP70 Tchem Tyrosine-protein kinase ZAP-70 (2189 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
AKT1 Tchem Serine/threonine-protein kinase AKT (9192 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
FLT3 Tclin Tyrosine-protein kinase receptor FLT3 (13481 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
PDK1 Tchem Pyruvate dehydrogenase kinase isoform 1 (2021 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
RPS6KB1 Tchem Ribosomal protein S6 kinase 1 (4456 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
MCF7 (126967 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
MDA-MB-468 (9477 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
PC-3 (62116 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
PrEC (20 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
SK-BR-3 (5175 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
HMEC (560 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
LNCaP (8286 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
MDA-MB-231 (73002 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ILK Tchem Serine/threonine-protein kinase ILK-1 (603 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ROS1 Tclin Proto-oncogene tyrosine-protein kinase ROS (2436 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
RICTOR Tbio Rapamycin-insensitive companion of mTOR (5 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
CDK5 Tchem Cyclin-dependent kinase 5/CDK5 activator 1 (3697 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
CDK1 Tchem Cyclin-dependent kinase 1/cyclin B1 (1887 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID

关联靶点(其它种属)

Mus musculus (284745 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID

作用机制

作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献

名称和识别符

分子类型 小分子
IIUPAC Name N-methyl-3-[1-(4-piperazin-1-ylphenyl)-5-[4-[4-(trifluoromethyl)phenyl]phenyl]pyrazol-3-yl]propanamide
INCHI 1S/C30H30F3N5O/c1-34-29(39)15-10-25-20-28(38(36-25)27-13-11-26(12-14-27)37-18-16-35-17-19-37)23-4-2-21(3-5-23)22-6-8-24(9-7-22)30(31,32)33/h2-9,11-14,20,35H,10,15-19H2,1H3,(H,34,39)
InChi Key GHBUPSVATJKTRR-UHFFFAOYSA-N
Smiles CNC(=O)CCC1=NN(C(=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)N5CCNCC5
Isomeric SMILES CNC(=O)CCC1=NN(C(=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)N5CCNCC5
MeSH Entry Terms N-methyl-3-(1-(4-(piperazin-1-yl)phenyl)-5-(4'-(trifluoromethyl)-(1,1'-biphenyl)-4-yl)-1H-pyrazol-3-yl)propanamide;N-methyl-PPTBPP;OSU-T315
分子量 533.59
Reaxy-Rn 21888688
Reaxys-RN link address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=21888688&ln=

化学和物理性质

分子量 533.600 g/mol
XLogP3 5.100
氢键供体数Hydrogen Bond Donor Count 2
氢键受体数Hydrogen Bond Acceptor Count 7
可旋转键计数Rotatable Bond Count 7
精确质量Exact Mass 533.24 Da
单同位素质量Monoisotopic Mass 533.24 Da
拓扑极表面积Topological Polar Surface Area 62.200 Ų
重原子数Heavy Atom Count 39
形式电荷Formal Charge 0
复杂度Complexity 767.000
同位素原子数Isotope Atom Count 0
定义的原子立体中心计数Defined Atom Stereocenter Count 0
未定义的原子立体中心计数Undefined Atom Stereocenter Count 0
定义的键立体中心计数Defined Bond Stereocenter Count 0
未定义的键立体中心计数Undefined Bond Stereocenter Count 0
所有立体化学键的总数The total count of all stereochemical bonds 0
共价键合单元计数Covalently-Bonded Unit Count 1

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到8个结果

批号(Lot Number) 证书类型 货号
B2402420 分析证书 O412290
B2402421 分析证书 O412290
B2402452 分析证书 O412290
B2402453 分析证书 O412290
B2402454 分析证书 O412290
B2402455 分析证书 O412290
B2402456 分析证书 O412290
B2402573 分析证书 O412290

引用文献

1. Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J, Dedhar S.  (2000)  Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells..  Proc Natl Acad Sci USA,  97  (7): (3207-12).  [PMID:10716737]
2. Deng JT, Van Lierop JE, Sutherland C, Walsh MP.  (2001)  Ca2+-independent smooth muscle contraction. a novel function for integrin-linked kinase..  J Biol Chem,  276  (19): (16365-73).  [PMID:11278951]
3. Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D, Yan J, Sanghera J, Walsh MP, Dedhar S.  (2001)  Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343..  J Biol Chem,  276  (29): (27462-9).  [PMID:11313365]
4. Graff JR, Deddens JA, Konicek BW, Colligan BM, Hurst BM, Carter HW, Carter JH.  (2001)  Integrin-linked kinase expression increases with prostate tumor grade..  Clin Cancer Res,  (7): (1987-91).  [PMID:11448915]
5. Deng JT, Sutherland C, Brautigan DL, Eto M, Walsh MP.  (2002)  Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase..  Biochem J,  367  (Pt 2): (517-24).  [PMID:12144526]
6. Ito R, Oue N, Zhu X, Yoshida K, Nakayama H, Yokozaki H, Yasui W.  (2003)  Expression of integrin-linked kinase is closely correlated with invasion and metastasis of gastric carcinoma..  Virchows Arch,  442  (2): (118-23).  [PMID:12596061]
7. Troussard AA, Mawji NM, Ong C, Mui A, St -Arnaud R, Dedhar S.  (2003)  Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation..  J Biol Chem,  278  (25): (22374-8).  [PMID:12686550]
8. Ahmed N, Riley C, Oliva K, Stutt E, Rice GE, Quinn MA.  (2003)  Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid..  J Pathol,  201  (2): (229-37).  [PMID:14517840]
9. Bravou V, Klironomos G, Papadaki E, Taraviras S, Varakis J.  (2006)  ILK over-expression in human colon cancer progression correlates with activation of beta-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway..  J Pathol,  208  (1): (91-9).  [PMID:16278819]
10. Schaeffer DF, Assi K, Chan K, Buczkowski AK, Chung SW, Scudamore CH, Weiss A, Salh B, Owen DA.  (2010)  Tumor expression of integrin-linked kinase (ILK) correlates with the expression of the E-cadherin repressor snail: an immunohistochemical study in ductal pancreatic adenocarcinoma..  Virchows Arch,  456  (3): (261-8).  [PMID:20091050]
11. Pontier SM, Huck L, White DE, Rayment J, Sanguin-Gendreau V, Hennessy B, Zuo D, St-Arnaud R, Mills GB, Dedhar S et al..  (2010)  Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer..  Oncogene,  29  (23): (3374-85).  [PMID:20305688]
12. Chan J, Ko FC, Yeung YS, Ng IO, Yam JW.  (2011)  Integrin-linked kinase overexpression and its oncogenic role in promoting tumorigenicity of hepatocellular carcinoma..  PLoS ONE,  (2): (e16984).  [PMID:21347395]
13. Lee SL, Hsu EC, Chou CC, Chuang HC, Bai LY, Kulp SK, Chen CS.  (2011)  Identification and characterization of a novel integrin-linked kinase inhibitor..  J Med Chem,  54  (18): (6364-74).  [PMID:21823616]
14. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S.  (1998)  Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase..  Proc Natl Acad Sci USA,  95  (19): (11211-6).  [PMID:9736715]

溶液计算器